Viewing nowCombinationCitalopram 5/80 mg (Amlodipine Besylate, Valsartan)
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201802091 · Approved 2018.05.17 · Insurance code 647303350
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Amlodipine or Valsartan.
The recommended dose is 1 tablet once daily. Take with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows: ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination with the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: For patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn when taken in the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to this medication's active ingredients or similar drugs should not use it. Additionally, pregnant women, women who may become pregnant, and breastfeeding women should avoid taking this medication. Patients with severe impairment of kidney or liver function, certain heart diseases, and those with a history of angioedema should not take this medication. Patients with insufficient sodium or body fluids may experience hypotension; thus, their conditions should be assessed before starting treatment, and blood pressure and symptoms should be closely monitored during treatment. Patients with high potassium levels should have regular blood tests when taking this medication along with other drugs that may raise potassium levels. Patients with renal vascular issues or those who have undergone kidney transplantation should use this medication with caution, as kidney function may deteriorate. Patients with heart failure or after myocardial infarction should closely monitor kidney function changes while on this medication, and severe heart failure patients require special attention. This medication may cause various side effects such as hypotension, dizziness, headache, edema, indigestion, skin rash, etc.; therefore, if any unusual symptoms occur, patients should consult healthcare professionals immediately. Dizziness or fatigue may present during driving or operating machinery; caution is necessary. This medication may interact with other antihypertensive drugs, potassium supplements, diuretics, certain antibiotics, and lithium preparations, so if patients are taking other medications, they must inform their healthcare professionals. It is advised that pregnant or breastfeeding women do not take this medication, especially if planning to conceive, they should consult with a doctor. Safety and efficacy in children under the age of 18 have not been sufficiently established, and use in this population is not recommended. In case of overdose, severe hypotension or arrhythmias may occur, thus adhering to the dosage is crucial, and if any abnormal symptoms arise, patients should seek medical attention immediately.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1°C and 30°C. This will help preserve the medication's effectiveness over time.
Bright yellow circular film-coated tablet
28 tablets/box [14 tablets/PTP x 2], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.